NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
10.41 USD
+0.29 (+2.87%)
10.41 USD
0 (0%)
NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. NUS has only an average score on both its financial health and profitability. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
Each year in the past 5 years NUS had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 7.69%, NUS is doing good in the industry, outperforming 77.14% of the companies in the same industry.
NUS has a better Return On Equity (13.70%) than 82.86% of its industry peers.
NUS has a Return On Invested Capital of 4.08%. This is comparable to the rest of the industry: NUS outperforms 54.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 12.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS has a Profit Margin of 7.02%. This is in the better half of the industry: NUS outperforms 77.14% of its industry peers.
With a Operating Margin value of 3.87%, NUS perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
In the last couple of years the Operating Margin of NUS has declined.
The Gross Margin of NUS (67.20%) is comparable to the rest of the industry.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
NUS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NUS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.78 indicates that NUS is not in any danger for bankruptcy at the moment.
NUS has a better Altman-Z score (3.78) than 74.29% of its industry peers.
The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
NUS's Debt to FCF ratio of 4.29 is amongst the best of the industry. NUS outperforms 82.86% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
NUS has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: NUS outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.78 |
ROIC/WACC0.55
WACC7.45%
2.3 Liquidity
A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
NUS's Current ratio of 2.15 is in line compared to the rest of the industry. NUS outperforms 51.43% of its industry peers.
NUS has a Quick Ratio of 1.45. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS's Quick ratio of 1.45 is in line compared to the rest of the industry. NUS outperforms 54.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 64.29% over the past year.
The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
The Revenue for NUS has decreased by -12.10% in the past year. This is quite bad
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
Based on estimates for the next years, NUS will show a very strong growth in Earnings Per Share. The EPS will grow by 36.15% on average per year.
Based on estimates for the next years, NUS will show a decrease in Revenue. The Revenue will decrease by -5.71% on average per year.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
NUS is valuated cheaply with a Price/Earnings ratio of 7.54.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.43% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.15. NUS is valued rather cheaply when compared to this.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 6.61.
NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 85.71% of the companies in the same industry.
NUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.54 | ||
| Fwd PE | 6.61 |
4.2 Price Multiples
NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 91.43% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NUS is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.66 | ||
| EV/EBITDA | 4.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 36.15% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.53%, NUS has a reasonable but not impressive dividend return.
NUS's Dividend Yield is a higher than the industry average which is at 7.49.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2Y36.15%
EPS Next 3YN/A
10.41
+0.29 (+2.87%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change1.34%
Ins Owners2.08%
Ins Owner Change3.44%
Market Cap515.29M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price Target7.65 (-26.51%)
Short Float %4.77%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.54 | ||
| Fwd PE | 6.61 | ||
| P/S | 0.33 | ||
| P/FCF | 9.66 | ||
| P/OCF | 5.76 | ||
| P/B | 0.64 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 4.09 |
EPS(TTM)1.38
EY13.26%
EPS(NY)1.58
Fwd EY15.14%
FCF(TTM)1.08
FCFY10.35%
OCF(TTM)1.81
OCFY17.36%
SpS31.52
BVpS16.16
TBVpS13.58
PEG (NY)0.15
PEG (5Y)N/A
Graham Number22.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.78 |
F-Score6
WACC7.45%
ROIC/WACC0.55
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.54 and the Price/Book (PB) ratio is 0.64.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 10.87%.